« UC Merced Opens Today |
| Come Discuss the Neurosociety at the University of Pennsylvania's Cognitive Neuroscience Meeting Next Monday »
September 8, 2005
Using Brain Scans to Figure Out What Women Want
What will they think of next? MIT's Technology Review reports on the following:
"Drug companies make $2.5 billion a year selling Viagra, Cialis and Levitra to help men enjoy sex. Since more women suffer from sexual dysfunction than men, developing a drug that could double those sales would seem to be a no-brainer. Yet the pharmaceutical industry has failed women miserably -- there isn't a single sexual dysfunction drug on the market that can help them. Pfizer Inc. last year abandoned an eight-year Viagra study involving 3,000 women, conceding that its famous blue pill only works for men.
While Pfizer and other pharmaceutical titans have abandoned the pursuit of a Viagra for females as too complicated, a growing number of university researchers are reporting progress with the help of brain scanners and other technology.
Yes, they're watching women's brains while they have orgasms. And they're coming to some interesting conclusions."
While Big Phama may have given up on FSD, several smaller companies are making progress, including: Nastech Pharmaceutical (apomorphine HCI) in Phase II; Solvay Pharmaceuticals (Estratest) in Phase II; BioSante Pharmaceuticals (LibiGel) completed Phase II; and Palatin Technologies (PT-141) in Phase II.
+ TrackBacks (2) | Category: Neuropharma
- RELATED ENTRIES
- Chinese Cover of The Neuro Revolution
- The Neuro Revolution Lands In China
- How Neuroscience Will Change the World - My Interview on Reason.tv
- Neuroscience Hearing on Capitol Hill Wednesday Sept 29, 2pm
- The Neuro Revolution Published in Japan as "Neuro Wars"
- Neurotech 2010: Translational Researchers Highlight Innovation
- The Neuro Revolution in China Progressing
- Speakers for Neurotech 2010 - Boston, May 19-20